Literature DB >> 2380919

Residence time distributions of solutes in the perfused rat liver using a dispersion model of hepatic elimination: 2. Effect of pharmacological agents, retrograde perfusions, and enzyme inhibition on evans blue, sucrose, water, and taurocholate.

M S Roberts1, S Fraser, A Wagner, L McLeod.   

Abstract

The effect of altered physiological conditions on the residence time distributions of sucrose, water, and taurocholate in the rat liver were studied using a bolus injection and quantifying fraction of total outflow per ml-time profiles. Retrograde perfusions increased the residence times of sucrose and water markedly and were associated with very low hepatic availabilities for taurocholate. Resistance by the inlet sinusoids sphincters, which become outlet sphincters during retrograde perfusions, is suggested as the explanation for the observation. Infusions of noradrenaline, propranolol, and lidocaine resulted in relatively small changes in the mean residence times for sucrose and water with no apparent relationship existing between the efficiency number of taurocholate and volumes of either water or sucrose. Taurochenodeoxycholate resulted in an increase in the availability and mean residence time for taurocholate relative to no infusion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2380919     DOI: 10.1007/bf01062201

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  33 in total

1.  Residence time distributions of solutes in the perfused rat liver using a dispersion model of hepatic elimination: 1. Effect of changes in perfusate flow and albumin concentration on sucrose and taurocholate.

Authors:  M S Roberts; S Fraser; A Wagner; L McLeod
Journal:  J Pharmacokinet Biopharm       Date:  1990-06

2.  A dispersion model of hepatic elimination: 2. Steady-state considerations--influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activity.

Authors:  M S Roberts; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1986-06

3.  A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations.

Authors:  M S Roberts; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1986-06

4.  Models of hepatic elimination: comparison of stochastic models to describe residence time distributions and to predict the influence of drug distribution, enzyme heterogeneity, and systemic recycling on hepatic elimination.

Authors:  M S Roberts; J D Donaldson; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1988-02

5.  Models of hepatic drug clearance: discrimination between the 'well stirred' and 'parallel-tube' models.

Authors:  A B Ahmad; P N Bennett; M Rowland
Journal:  J Pharm Pharmacol       Date:  1983-04       Impact factor: 3.765

Review 6.  Physiologically based models and strategic experiments in hepatic pharmacology.

Authors:  L Bass; S Keiding
Journal:  Biochem Pharmacol       Date:  1988-04-15       Impact factor: 5.858

7.  Protein binding and hepatic clearance: discrimination between models of hepatic clearance with diazepam, a drug of high intrinsic clearance, in the isolated perfused rat liver preparation.

Authors:  M Rowland; D Leitch; G Fleming; B Smith
Journal:  J Pharmacokinet Biopharm       Date:  1984-04

8.  Effect of sinusoidal perfusion on galactose elimination kinetics in perfused rat liver.

Authors:  S Keiding; E Chiarantini
Journal:  J Pharmacol Exp Ther       Date:  1978-05       Impact factor: 4.030

9.  An enzyme-distributed system for lidocaine metabolism in the perfused rat liver preparation.

Authors:  K S Pang; J A Terrell; S D Nelson; K F Feuer; M J Clements; L Endrenyi
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

10.  The multiple-indicator dilution technique for characterization of normal and retrograde flow in once-through rat liver perfusions.

Authors:  M V St-Pierre; A J Schwab; C A Goresky; W F Lee; K S Pang
Journal:  Hepatology       Date:  1989-02       Impact factor: 17.425

View more
  6 in total

1.  A comparative investigation of hepatic clearance models: predictions of metabolite formation and elimination.

Authors:  M V St-Pierre; P I Lee; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1992-04

2.  Application of the dispersion model for description of the outflow dilution profiles of noneliminated reference indicators in rat liver perfusion studies.

Authors:  A J Schwab; W Geng; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1998-04

3.  Assessing the cellular transmembrane electrical potential difference on the hepatic uptake of palmitate.

Authors:  F J Burczynski; D Hung; G Q Wang; B Elmadhoun; A Lewis; P Chang; G Rajaraman; S Robert
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

4.  Estimation of aqueous distributional spaces in the dual perfused rat liver.

Authors:  S Sahin; M Rowland
Journal:  J Physiol       Date:  2000-10-01       Impact factor: 5.182

5.  Estimation of hepatic distributional volumes using non-labeled reference markers.

Authors:  Yasemin Karabey; Selma Sahin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Oct-Dec       Impact factor: 2.441

6.  Stereoselective hepatic disposition of model diastereomeric acyl glucuronides.

Authors:  David M Shackleford; Roger L Nation; R W Milne; P J Hayball; Allan M Evans
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-02       Impact factor: 2.745

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.